KLI
Login
OAK 국가리포지터리
검색
커뮤니티
제목
저자
키워드
발행일
Ulsan Univ. Repository
Browsing by 저자 : Byoung Chul Cho
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
또는 첫 단어:
정렬 기준:
제목
발행일
제출일
정렬:
오름차순
내림차순
결과 수
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
저자 수
All
1
3
5
10
15
20
25
30
35
40
45
50
전체 결과 9건 중 1-9 번을 표시중입니다.
1
Article
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors
Byoung Chul Cho
;
Ji-Youn Han
;
Sang-We Kim
;
et al
2022
2
Article
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
김상위
;
Amy Roshak
;
Byoung Chul Cho
;
et al
2021
3
Article
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer
이대호
;
Adnan Nagrial
;
Byoung Chul Cho
;
et al
2021
4
Article
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
이대호
;
Byoung Chul Cho
;
Chia-Chi Lin
;
et al
2020
5
Article
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study
김상위
;
Anders Mellemgaard
;
Byoung Chul Cho
;
et al
2020
6
Article
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
이대호
;
Aaron S Mansfield
;
Benjamin Besse
;
et al
2021
7
Article
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
김상위
;
Bong-Seog Kim
;
Byoung Chul Cho
;
et al
2020
8
Article
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis
김상위
;
Byoung Chul Cho
;
Cheol Hyeon Kim
;
et al
2020
9
Article
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3)
Morihito Okada
;
Ken Kato
;
Byoung Chul Cho
;
et al
2022
1
Anonymous
Login
커뮤니티
제목
저자
키워드
발행일
Guide